Do peripheral blasts count in myelodysplastic syndromes?

Leukemia Research

Volumn 33, Issue 2, 2009, Pages 209-211

  Alhan, Canan ^a   Westers, Theresia M ^a   Ossenkoppele, Gert J ^a   van de Loosdrecht, Arjan A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Circulating blasts; Flow cytometry; Myelodysplastic syndrome; Prognostic factor

Indexed keywords

LACTATE DEHYDROGENASE;

ACUTE GRANULOCYTIC LEUKEMIA; ANEMIA; BLAST CELL; BONE MARROW DEPRESSION; CD34 SELECTION; CELL COUNT; CYTOPENIA; DISEASE CLASSIFICATION; DISEASE COURSE; EDITORIAL; FLOW CYTOMETRY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

ANTIGENS, CD34; BLAST CRISIS; FLOW CYTOMETRY; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MYELODYSPLASTIC SYNDROMES; PROGNOSIS;

EID: 56949100372     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.06.015     Document Type: Editorial

References (19)

1. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Brit J Haematol 51 (1982) 189-199
2. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
3. Valent P., Horny H.P., Bennett J.M., Fonatsch C., Germing U., Greenberg P., et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 31 (2007) 727-736
4. Loken M.R., van de Loosdrecht A.A., Ogata K., Orfao A., and Wells D.A. Flow cytometry in myelodysplastic syndromes: report from a working conference. Leuk Res 32 (2008) 5-17
5. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
6. Verburgh E., Achten R., Louw V.J., Brusselmans C., Delforg M., Boogaerts M., et al. A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification. Leukemia 21 (2007) 668-677
7. Malcovati L., Germing U., Kuendgen A., Della Porta M.G., Pascutto G., Invernizzi R., et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25 (2007) 3503-3510
8. Bowen D.T., Fenaux P., Hellström-Lindberg E., and de Witte T. Time-dependent prognostic scoring system for myelodysplastic syndromes has significant limitations that may influence its reproducibility and practical application. J Clin Oncol 26 (2008) 1180
9. Germing U., Hildebrandt B., Pfeilstöcker M., Nösslinger T., Valent P., Fonatsch C., et al. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). Leukemia 19 (2005) 2223-2231
10. Haase D., Germing U., Schanz J., Pfeilstöcker M., Nösslinger T., Hildebrandt B., et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 110 (2007) 4385-4395
11. Font P., Subirá D., Mtnez-Chamorro C., Castanón S., Arranz E., Ramiro S., et al. Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome. Leuk Res 30 (2006) 957-963
12. Ogata K., Kishikawa Y., Satoh C., Tamura H., Dan K., and Hayashi A. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 108 (2006) 1037-1044
13. van de Loosdrecht A.A., Westers T.M., Westra A.H., Dräger A.M., van der Velden V.H.J., and Ossenkoppele G.J. Identification of distinct prognostic subgroups in low and intermediate-1 risk myelodysplastic syndromes by flow cytometry. Blood 111 (2008) 1067-1077
14. Wells D.A., Benesch M., Loken M.R., Vallejo C., Myerson D., Leisenring W.M., et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 102 (2003) 394-403
15. Cesana C., Klersy C., Brando B., Nosari A., Scarpati B., Scampini L., et al. Prognostic value of circulating CD34+ cells in myelodysplastic syndromes. Leuk Res 32 (2008) 1715-1723
16. Knipp S., Strupp C., Gatterman N., Hildebrandt B., Schapira M., Giagounidids A., et al. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome. Leuk Res 32 (2008) 33-37
17. Fuchigami K., Mori H., Matsuo T., Iwanaga M., Nagai K., Kuriyama K., et al. Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry. Leuk Res 24 (2000) 163-174
18. Sullivan S.A., Marsden K.A., Lowenthal R.M., Jupe D.M., and Jones M.E. Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syndromes. Am J Hematol 39 (1992) 96-101
19. Timeus F., Crescenzio N., Doria A., Foglia L., Linari A., Giaccone M., et al. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia. Exp Hematol 33 (2005) 597-604